QNatal® Advanced
noninvasive prenatal screening
Empowering better access to important prenatal screening
QNatal® Advanced is a noninvasive cell-free DNA (cfDNA) prenatal screen that screens for the most common fetal aneuploidies, including Down syndrome. In addition, if elected, QNatal Advanced can screen for certain microdeletions and/or fetal sex. Test code 92777
While many may offer prenatal screening, we deliver on the promise of making advanced screening more accessible.
Prenatal screening should be available to all. 76% of patients pay less than $99.a
Access made easy
We make QNatal Advanced testing more accessible with cost transparency, financial tools, and support at every step. It starts by being in-network with the majority of health plans nationwide.
Understanding costs
This QNatal Advanced Cost Estimator provides estimated out-of-pocket costs specific to each woman and her pregnancy, her health plan, and her deductible, resulting in a personalized estimate.
Prior authorization (PA) services for all orders
Orders are routed automatically to our Specialty Testing Services (STS) team who works with a patient’s health plan to determine coverage and need for prior authorization. Email Preauthorization_PrenatalScreening@QuestDiagnostics.com or call 1.888.445.5011.
Flexible financial options
We are committed to helping your patients receive prenatal screening at a lower cost.
Helping provide patients better peace of mindc
QNatal® Advanced is a noninvasive cell-free DNA (cfDNA) prenatal screen that screens for the most common fetal aneuploidies, including Down syndrome. In addition, if elected, QNatal Advanced can screen for certain microdeletions and/or fetal sex. Test code 92777
High-quality prenatal screening
Comprehensive screening, easy-to-read results
Helping provide patients better peace of mindc
QNatal® Advanced is a noninvasive cell-free DNA (cfDNA) prenatal screen that screens for the most common fetal aneuploidies, including Down syndrome. In addition, if elected, QNatal Advanced can screen for certain microdeletions and/or fetal sex. Test code 92777
High-quality prenatal screening
Comprehensive screening, easy-to-read results
Access to advanced screening and accurate results from a single source.c
That’s our promise to you and your patients.
Access to advanced testing and reliable results from a single source.
That’s our promise to you and your patients.
Click here for more information and to order QNatal Advanced
a Claims analysis. Data on file. Quest Diagnostics, 2020.
b Alternative UPP pricing is available in Florida, New Hampshire, Massachusetts, Maine, Rhode Island, Vermont, and Texas
c QNatal® Advanced is a cell-free DNA test that screens for increased risk of certain fetal chromosomal abnormalities that may cause birth defects, including Trisomy 21 (Down Syndrome), Trisomy 18, Trisomy 13, and certain sex chromosome abnormalities (ie, 45,X, 47,XXY, 47,XXX, and 47,XYY). In addition, if selected as an option, QNatal Advanced can screen for certain microdeletions (ie, 22q, 5p, 1p36, 15q, 11q, 8q, and 4p) that may cause birth defects, and/or for fetal sex. This test does not assess the risk of fetal anomalies such as neural tube defects or ventral wall defects. QNatal Advanced must not be used earlier than 10 weeks into pregnancy. QNatal Advanced is not recommended before 10 weeks gestation due to a significantly increased risk of a failed result.
QNatal is a “screening” test, not a diagnostic test, and therefore all positive/increased risk results should be followed by genetic counseling and further diagnostic testing and procedures, when clinically indicated. Pregnancy management decisions should not be based on the results of a cfDNA test alone. As with any test, there may be false positives or false negatives. The positive predictive value of the screening test varies by genetic marker, and may be lower for rare conditions. Performance data for the QNatal Advanced may be obtained by contacting Quest Diagnostics at 1.866.GENE.INFO (1.866.436.3463).
QNatal Advanced is a laboratory developed test that has been developed and validated, pursuant to the Clinical Laboratory Improvements Amendments of 1988 (CLIA), and as such it has not been reviewed by FDA.
d Guy C, Haji-Sheikhi F, Rowland CM, et al. Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory. Mol Genet Genomic Med. 2019;7(3):e545. doi:10.1002/mgg3.545 (finding a no-call rate of 3.5%; several authors affiliated with Quest Diagnostics). “No call rate” refers to the percentage of samples for which results could not be reported.
This test is offered as QNatal Advanced in all states other than California.
Test codes may vary by location. Please contact your local laboratory for more information.
Image content features models and is intended for illustrative purposes only.
Genetic consultation available
CertifiedBoard-certified counselors are available to help with test selection and results interpretation 1.866.GENE.INFO (1.866.436.3463).
